Search Results - "Vasilogianni, Areti‐Maria"
-
1
Quantitative Proteomics of Hepatic Drug‐Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis
Published in Clinical pharmacology and therapeutics (01-09-2022)“…The impact of liver cancer metastasis on protein abundance of 22 drug‐metabolizing enzymes (DMEs) and 25 transporters was investigated using liquid…”
Get full text
Journal Article -
2
Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects
Published in British journal of clinical pharmacology (01-02-2022)“…Aims This study aims to quantify drug‐metabolising enzymes, transporters, receptor tyrosine kinases (RTKs) and protein markers (involved in pathways affected…”
Get full text
Journal Article -
3
Mass spectrometry‐based abundance atlas of ABC transporters in human liver, gut, kidney, brain and skin
Published in FEBS letters (01-12-2020)“…ABC transporters (ATP‐binding cassette transporter) traffic drugs and their metabolites across membranes, making ABC transporter expression levels a key factor…”
Get full text
Journal Article -
4
Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis
Published in Frontiers in oncology (20-02-2023)“…Alterations in expression and activity of human receptor tyrosine kinases (RTKs) are associated with cancer progression and in response to therapeutic…”
Get full text
Journal Article -
5
Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis
Published in Drug metabolism and disposition (01-07-2021)“…In vitro-in vivo extrapolation (IVIVE) linked with physiologically based pharmacokinetics (PBPK) modeling is used to predict the fates of drugs in patients…”
Get full text
Journal Article -
6
Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters
Published in Drug metabolism and disposition (01-06-2022)“…Building and refining pharmacology models require "system" data derived from tissues and in vitro systems analyzed by quantitative proteomics. Label-free…”
Get full text
Journal Article -
7
Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease
Published in Journal of proteomics (15-07-2022)“…Model-based assessment of drug pharmacokinetics in liver disease requires quantification of abundance and disease-related changes in hepatic enzymes and…”
Get full text
Journal Article -
8
Quantitative mass spectrometry-based proteomics in the era of model-informed drug development: Applications in translational pharmacology and recommendations for best practice
Published in Pharmacology & therapeutics (Oxford) (01-11-2019)“…Quantitative translation of the fate and action of a drug in the body is facilitated by models that allow extrapolation of in vitro measurements (such as the…”
Get full text
Journal Article -
9
Toxicity assessment and comparison of the land snail's Cornu aspersum responses against CuO nanoparticles and ZnO nanoparticles
Published in Comparative biochemistry and physiology. Toxicology & pharmacology (01-10-2020)“…The goal of the present study was to examine the effects of ZnO NPs and CuO NPs on Cornu aspersum land snail, enlightening their cytotoxic profile. ZnO NPs and…”
Get full text
Journal Article -
10
A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins
Published in Journal of proteomics (15-06-2022)“…We have developed a family of QconCAT standards for the absolute quantification of pharmacological target proteins in a variety of human tissues. The QconCATs…”
Get full text
Journal Article -
11
Impact of Gastrointestinal (Gi) and Hepatic Cancer on Enzyme and Transporter Abundance Contributing to Variability in Drug Exposure
Published 01-01-2021“…Clinical trials in oncology recruit heterogeneous participants not often representative of the target cohort, leading to large variability in pharmacokinetics…”
Get full text
Dissertation